Showing results (31-40 of 175) with videos related to
Sort By:
Pageof 18
Epilepsy & Behavior : E&B|September 25, 2023
The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?Elinor Ben-Menachem, Bettina Schmitz, Reetta Kälviäinen, et al.Multiple Sclerosis and Related Disorders|January 23, 2022
Incidence of persistent lymphopenia in people with multiple sclerosis on dimethyl fumarateCallum H Wood, Neil P Robertson, Zin Min Htet, et al.Journal of Neurology|February 11, 2024
Prodromal multiple sclerosis: considerations and future utilityKatharine E Harding, Karim L Kreft, Yoav Ben-Shlomo, et al.Expert Review of Neurotherapeutics|June 17, 2014
Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsyMatthias J Koepp, Rhys H Thomas, Britta Wandschneider, et al.Practical Neurology|July 22, 2010
Epilepsy: creative sparksRhys H Thomas, Jane M Mullins, Tracey Waddington, et al.Seizure|November 25, 2010
Implications for families of advances in understanding the genetic basis of epilepsyCarrie L Hammond, Rhys H Thomas, Mark I Rees, et al.Epilepsy & Behavior : E&B|October 23, 2012
Translation of genetic findings to clinical practice in juvenile myoclonic epilepsyRhys H Thomas, Seo-Kyung Chung, Khalid Hamandi, et al.Epilepsy & Behavior Reports|May 27, 2022
A review of the clinical spectrum of <i>BRAT1</i> disorders and case of developmental and epileptic encephalopathy surviving into adulthoodRoss Fowkes, Menatalla Elwan, Ela Akay, et al.Epilepsy & Behavior Reports|June 17, 2022
Late-onset cluster seizures and intellectual disability associated with a novel truncation variant in <i>SMC1A</i>Menatalla Elwan, Ross Fowkes, David Lewis-Smith, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2014
The aetiology of acute neurological decline in multiple sclerosis: experience from an open-access clinicEmma C Tallantyre, Emmie G Causon, Katharine E Harding, et al.Pageof 18